Description
Adlinameg 2.5/500 mg is an oral antidiabetic medication combining two effective agents: Linagliptin and Metformin. It is designed to help manage blood glucose levels in adults with type 2 diabetes mellitus, especially when diet, exercise, and single-drug therapy are insufficient.
-
Linagliptin is a DPP-4 inhibitor that increases the levels of incretin hormones, enhancing insulin secretion and decreasing glucagon levels in a glucose-dependent manner.
-
Metformin is a biguanide that improves insulin sensitivity and reduces glucose production in the liver.
Together, they work synergistically to improve glycemic control without causing significant weight gain or increasing the risk of hypoglycemia when used appropriately.
 20ML.jpeg)
 200ML.webp)
 250 ML.jpeg)
 200ML.jpg)
.webp)
 125ML.webp)
 125ML.jpg)
 200ML.webp)
 200 ML.jpeg)
.webp)
60 ML 60 ML.webp)
 150GM.webp)
 30 TAB.webp)
 50ML.webp)
 15ML.webp)
 40 ML.png)
 100ML.png)
Change Language